Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 658, pseudogene (RN7SL658P)

Target
RN7SL658P
Molecular classification
Other (Pseudogene), Non-coding RNA pseudogene
01

Overview

RN7SL658P is classified as a *pseudogene* related to RNA, 7SL, cytoplasmic, which is a component of the signal recognition particle (SRP) RNA family[1][5]. It does not encode a functional RNA product and is considered non-coding. The canonical, functional form of 7SL RNA is essential for directing newly synthesized proteins to the endoplasmic reticulum, but **RN7SL658P** represents an *inactive, non-functional copy* (pseudogene) and does not participate in this pathway[1][5]. Pseudogenes such as RN7SL658P are usually generated through duplication or retrotransposition events. While some pseudogenes may play roles in gene regulation or act as competitive endogenous RNAs in rare cases[2], there is currently no evidence that RN7SL658P possesses such functions. Key context: - This target is **not a therapeutic target**, receptor, enzyme, transporter, or otherwise[1][5]. - As a pseudogene, RN7SL658P does not encode a functional biomolecule and is generally not considered relevant to drug-target or biomarker research in its own right[1][5]. - The entry is not misspelled, but it is often not useful for therapeutic targeting or functional studies, making its "target" status incorrect by standard definitions.

Other names
RN7SL658PRNA, 7SL, cytoplasmic 658, pseudogene
02

Biological functions

Other (No established biological function for the pseudogene; see below for general notes on related functional genes)
03

Disease associations

Other (No direct disease association for this pseudogene)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 658, pseudogene (RN7SL658P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 658, pseudogene (RN7SL658P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call